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Abstract
Background: Klebsiella pneumoniae displaying the hypermucoviscosity (HV) phenotype are considered more
virulent than HV-negative strains. Nevertheless, the emergence of tissue-abscesses-associated HV-negative isolates
motivated us to re-evaluate the role of HV-phenotype.
Results: Instead of genetically manipulating the HV-phenotype of K. pneumoniae, we selected two clinically
isolated K1 strains, 1112 (HV-positive) and 1084 (HV-negative), to avoid possible interference from defects in the
capsule. These well-encapsulated strains with similar genetic backgrounds were used for comparative analysis of
bacterial virulence in a pneumoniae or a liver abscess model generated in either naïve or diabetic mice. In the
pneumonia model, the HV-positive strain 1112 proliferated to higher loads in the lungs and blood of naïve mice,
but was less prone to disseminate into the blood of diabetic mice compared to the HV-negative strain 1084. In the
liver abscess model, 1084 was as potent as 1112 in inducing liver abscesses in both the naïve and diabetic mice.
The 1084-infected diabetic mice were more inclined to develop bacteremia and had a higher mortality rate than
those infected by 1112. A mini-Tn5 mutant of 1112, isolated due to its loss of HV-phenotype, was avirulent to mice.
Conclusion: These results indicate that the HV-phenotype is required for the virulence of the clinically isolated
HV-positive strain 1112. The superior ability of the HV-negative stain 1084 over 1112 to cause bacteremia in
diabetic mice suggests that factors other than the HV phenotype were required for the systemic dissemination of
K. pneumoniae in an immunocompromised setting.
Background
As a common pathogen responsible for a wide range of
clinical illnesses, K. pneumoniae has long been the prin-
cipal cause of pneumonia [1], emerging as the major
pathogen associated with pyogenic liver abscesses over
the past decade [2]. K. pneumoniae has been implicated
in 7-12% of hospital-acquired pneumoniae in ICUs in
the United States [3,4], accounting for 15, 32, and 34%
of community-acquired pneumoniae in Singapore [5],
Africa [6], and Taiwan [7], respectively. In the 1990 s,
K. pneumoniae surpassed E. coli as the number one iso-
late from patients with pyogenic liver abscesses in Tai-
wan [8], where more than 1,000 cases have been
reported [2]. Liver abscesses caused by K. pneumoniae
(KLA) have become a health problem in Taiwan and
continue to be reported in other countries. Metastatic
lesions, such as meningitis and endophthalmitis, develop
in 10-12% of KLA patients and, worsening the prognosis
of this disease [2]. Cases of KLA in Taiwan typically
occur in diabetic patients with a prevalence rate from
45% to 75% [9,10].
Diabetes mellitus (DM), the most common endocrine
disease, is a predisposing factor for infections of
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K. pneumoniae [9]. Type 1 diabetes (IDDM) is a form of
DM resulting from autoimmune triggered destruction of
insulin-producing b cells of the pancreas. Type 2 dia-
betes (NIDDM) is characterized by high blood glucose
within the context of insulin resistance and relative
insulin deficiency. In 2000, approximately 171 million
people in the United States were affected by diabetes,
and this number is expected to grow to 366-440 million
by 2030 [11]. Diabetes can lead to a variety of sequelae,
including retinopathy, nephropathy, neuropathy, and
numerous cardiovascular complications, and patients
with diabetes are more prone to infection. Several fac-
tors predispose diabetic patients to infection, including
genetic susceptibility, altered cellular and humoral
immune defense mechanisms, poor blood supply, nerve
damage, and alterations in metabolism [12].
Clinical K. pneumoniae isolates produce significant
quantities of capsular polysaccharides (CPS). Several
CPS-associated characteristics have been identified in
correlation with the occurrence of KLA, including sero-
type K1 or K2 [13] and a mucopolysaccharide web out-
side the capsule, also known as the hypermucoviscosity
(HV) phenotype [14]. We collected 473 non-repetitive
isolates from the foci of K. pneumoniae-related infec-
tions. Interestingly, the incidence of strains displaying
the HV phenotype in the K. pneumoniae abscess isolates
was 51% (48/94), which was significantly lower than that
reported by Yu et al. (29/34, 85%) [15] and Fang et al.
(50/53, 98%) [14]. A decline in the HV-positive rate sug-
gests the emergence of etiological HV-negative strains
and urges a re-evaluation of whether the HV phenotype
acts as a virulence determinant for clinical K. pneumo-
niae isolates. Due to the significant susceptibility of dia-
betic patients, this study established two infection
models recapitulating pneumonia and KLA in diabetic
and naïve C57BL/6J mice. The role of the HV pheno-
type in the pathogenesis of K. pneumoniae was deter-
mined in these mouse models by comparatively
analyzing bacterial virulence for two clinically isolated
K1 strains, 1112 and 1084, which were well-encapsu-
lated with similar genetic backgrounds; however, only
1112 exhibited the HV-phenotype.
Results
Emergence of HV-negative K. pneumoniae related to
tissue abscesses
To determine the clinical impact of the HV characteris-
tics, 473 non-repetitive isolates were collected from con-
secutive patients exhibiting K. pneumoniae-related
infections under treatment at a referral medical center
in central Taiwan, during April 2002-June 2003. Of the
clinical isolates, 7% (n = 35) were KLA strains, obtained
from tissue-invasive cases presenting the formation of
liver abscesses; 13% (n = 59) were isolated from non-
hepatic abscesses, including lesions occurring as
empyema, endophthalmitis, necrotizing fasciitis, and
septic arthritis, as well as lung, epidural, parotid, para-
spinal, splenic, renal, prostate, muscle, and deep neck
abscesses; 24% (n = 113) were obtained from non-
abscess-related cases, including pneumonia without
abscess, primary peritonitis, cellulitis, biliary tract infec-
tion, primary bacteremia, and catheter-related infections;
and 56% (n = 265) were secondary K. pneumoniae infec-
tions. The HV-phenotype of the 473 strains was deter-
mined using the string-forming test (Figure 1A).
Interestingly, the HV-positive rate in the tissue-abscess
isolates (n = 94) was only 51%, which was significantly
lower than that reported by Yu et al. (29/34, 85%) [15]
and Fang et al. (50/53, 98%) [14]. In particular, the tis-
sue-abscess isolates from diabetic patients were more
frequently HV-negative than those from non-diabetic
patients (54% vs. 40%; Figure 1B). Moreover, HV-nega-
tive K. pneumoniae accounted for the majority of cases
related to pneumonia (n = 47; 66%) and secondary bac-
teremia (n = 37) (Figure 1C). Although HV-negative
K. pneumoniae are considered less virulent than HV-
positive strains, our epidemiological observations
indicate that K. pneumoniae strains displaying no HV-
phenotype have emerged as etiological agents for tissue-
abscesses.
Analysis of comparative virulence for HV-positive and-
negative K. pneumonia
Under the premise that capsules are unaffected, we
selected two clinically isolated K1 strains, 1112 (HV-
positive) and 1084 (HV-negative) instead of using
genetically manipulated strains to evaluate the role of
HV phenotype in K. pneumoniae pathogenesis. Both
strains were well-encapsulated with the only phenotypic
differences in the HV-phenotype, displaying a relatively
high genetic identity (>98%) on their PFGE-XbaI pulso-
types among the 473 clinical isolates (Figure 1D).
Bacterial virulence of the HV-positive strain 1112 and-
negative strain 1084 was analyzed comparatively in a
pneumoniae or KLA infection model generated in either
diabetic or naïve mice. A multi-STZ injection method
[16] was used to induce diabetes in mice. The random
blood sugar levels of the STZ-treated mice was signifi-
cantly higher than those of naïve mice at eight weeks
(301.86 vs. 123.97 mg/dl, P ≤ 0.05; Additional file 1:
Figure S1A) and thirty weeks (404.36 vs. 121.09 mg/dl,
P ≤ 0.05) post-injection in conjunction with the classical
symptoms of polyuria, polydipsia, polyphagia, and hyper-
glycemia, exhibited in STZ-treated mice, the body
weight of the mice was also lowered significantly in a
time-dependent manner (Additional file 1: Figure S1B).
These results indicate that diabetes was successfully
induced in these mice. To recapitulate a pneumonia
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Figure 1 Prevalence of HV phenotype among clinical K. pneumoniae isolates. (A) A mucoviscous string formed between an inoculation
loop and the colony of a HV-positive strain. (B) Occurrence of HV-positive (black columns) or HV-negative (white columns) isolates in patients
with or without diabetic mellitus (DM or Non-DM). (C) Prevalence of HV-positive K. pneumoniae among patients suffering from various infections,
including KLA, non-hepatic abscess, pneumonia, primary bacteremia, and secondary bacteremia. (D) Dendrogram of the HV-positive strain 1112
and-negative strain 1084. Genetic similarities were calculated using UPGMA.
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infection, 30-wk-old diabetic mice or age-matched naïve
mice were intratracheally inoculated with 104 CFU of
K. pneumoniae 1112 (HV-positive) or 1084 (HV-negative).
At 20 h post-infection (hpi), 1112 demonstrated a signifi-
cantly higher proliferation of 1084 in the lungs (Figure 2A,
P < 0.05) and blood of naïve mice (Figure 2B, P < 0.05).
However, 1084 (the HV-negative strain) had a significant
growth advantage in the blood of diabetic mice compared
to that of naïve mice (Figure 2B, P < 0.05). This growth
advantage of 1084 in the blood of diabetic mice was absent
for 1112 (Figure 2B).
Previous studies have suggested that liver abscesses are
caused mostly by HV-positive K. pneumoniae [14]. Never-
theless, 46% of our KLA isolates lacked the HV-phenotype,
which encouraged us to determine the importance of the
HV-phenotype for K1 K. pneumoniae in the development
of KLA. Based on the KLA model established in our pre-
vious study [17], 30-wk-old diabetic or age-matched naïve
mice were orally inoculated with 1112 or 1084. Bacterial
loads in the blood were determined at 24, 48, and 72 hpi
to evaluate the tissue-invasiveness of these strains. Inter-
estingly, 50% (4/8) of the 1084-infected diabetic mice
developed bacteremia at 48 hpi with average bacterial load
of 4.6 × 103 CFU/ml (Figure 2C), whereas only 14% (1/7)
of the 1112-infected diabetic mice had bacteria in the
blood (Figure 2D). The enhanced invasiveness of 1084
contributed to its virulence in diabetic mice, as 37.5% (3/
8) of diabetic mice succumbed to 1084 infection, whereas
none of the 1112-infected diabetic mice died before day, 4
post-infection (Figure 2G). However, the superior viru-
lence of 1084 over 1112 in diabetic mice was absent in
naïve mice. Compared to the presence of 1112 in 70% (7/
10) of the infected mice (Figure 2F), 1084 was only
detected in the blood of 33.3% (2/6) of the infected naïve
mice (Figure 2E). Seven of ten 1112-infected naïve mice
died at day 4 but only one of the six 1084-infected naïve
mice died at precisely the same time (Figure 2H). Regard-
less of the HV-phenotype, both 1112 and 1084 induced
microabscess foci in the livers at seven days post-inocula-
tion, compared to the control group (Figure 3A, B), as sig-
nificant infiltrates of polymorphonuclear leukocytes were
noted in either the diabetic mice (Figure 3C, E) or the
naïve mice (Figure 3 D, F).
Requirement of HV-phenotype for K. pneumoniae 1112
virulence
The HV-positive strain, 1112, demonstrated stronger viru-
lence than 1084 in naïve mice. To determine whether the
virulence of 1112 was determined by the expression of
HV-phenotype, we isolated a mutant that lost its HV-phe-
notype from a mini-Tn5 mutant library of 1112 and desig-
nating it KPG6. Based on sequence determination, the
mini-Tn5 in KPG6 was inserted into the reading frame of
pgi. Glucose-6-phosphate isomerase, encoded by pgi, is
one of the key enzymes responsible for exopolysaccharide
synthesis of Klebsiella [18]. Compared to its parental strain
1112, the HV-negative mutant KPG6 was more sensitive
to serum-killing and its virulence in naïve BALB/c mice
was significantly attenuated with > 100 fold increase in the
oral LD50 (Table 1). Additionally, the loss of HV-pheno-
type also impaired the anti-phagocytosis ability, as the
intracellular survival of KPG6 was lower in Raw264.7
macrophages than that of 1112 (Table 1). These results
suggest that the HV-phenotype was a virulence determi-
nant for the HV-positive strain 1112.
Discussion
A capsule-associated mucopolysaccharide web, also
known as the hypermucoviscosity (HV) phenotype, was
previously considered a characteristic associated with
pyogenic K. pneumoniae infections [14,15]. Nevertheless,
the prevalence of K. pneumoniae negative for HV-phe-
notype in our pyogenic cases (49%; 46/94) suggests that
HV-negative strains have emerged as etiologic in the
formation of tissue abscesses. HV-negative-associated
infections were related to diabetic conditions, as diabetic
patients suffering from pyogenic infections were more
frequently associated with HV-negative strains than with
HV-positive strains (70% vs. 56%). Therefore, in this
study, we aimed to assess how essential the HV-pheno-
type is for K. pneumoniae pathogenesis by comparing
the virulence of clinically isolated strains that were natu-
rally HV-positive or -negative. Because K1 is the predo-
minant serotype in KLA cases, we selected two K1
strains, 1112 and 1084, which have relatively high
genetic similarity among our clinical isolates. Not sur-
prisingly, the HV-positive strain 1112 demonstrated
greater virulence than the HV-negative strain 1084 in
either a pneumonia or KLA infection model in naïve
mice. However, in the KLA model of diabetic mice,
1084 was as potent as 1112 in inducing liver abscesses,
exhibiting an ability superior to that of 1112 in causing
bacteremia and mortality in mice. The advantageous tis-
sue-invasive ability of 1084 indicates that the HV-phe-
notype per se is not a determinant for K. pneumoniae
virulence in a diabetic host.
Genetic loci, including magA [14], the cps gene cluster
[19], the wb gene cluster [20], and rmpA [21], have been
associated with the HV-phenotype. Mutations of these
genes have resulted in the loss of the HV-phenotype in
conjunction with defects in capsular integrity, confirm-
ing the findings of Fang et al. [14], who reported that
capsule-related properties, including serum resistance,
anti-phagocytosis, and virulence to mice, were drastically
attenuated in the magA mutants. Ideally, the capsule
and HV-phenotype should be investigated indepen-
dently. However, all of the HV-phenotype-associated
genes identified thus far are involved in the regulation
Lin et al. BMC Microbiology 2011, 11:50
http://www.biomedcentral.com/1471-2180/11/50
Page 4 of 8
Figure 2 Analysis of comparative virulence analysis for HV-positive and -negative K. pneumoniae. In the pneumonia model, bacterial
counts in the lung (A) and blood (B) at 20 hours post-infection with the HV-negative 1084 or the HV-positive 1112 were determined in diabetic
mice (filled columns) or naïve mice (striped columns). In the KLA model, 1084 (C, E) and 1112 (D, F) were orally inoculated into diabetic mice
with inoculums of 105 CFU (C, D) or into naïve mice with inoculums of 108 CFU (E, F). Twenty microliters of blood was removed from the
retroorbital sinus of mice at 24 h, 48 h, and 72 h post-inoculation; and the bacterial loads were determined using the plate-counting method.
Each symbol represents the data obtained from a particular mouse. The bacterial load recovered from a particular mouse tissue, which was
beyond the detection limit (approximately 40 CFU), is not represented. Survival of these mice was monitored daily for seven days. The survival
rate of the 1112-infected (solid line) or the 1084-infected (dotted line) diabetic (G) or naïve (H) mice was determined by Kaplan-Meier analysis.
Data were compiled from results obtained from three independent experiments.
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or the biosynthesis of capsular polysaccharides. Given
that significant quantities of clinically isolated K. pneu-
moniae are well-encapsulated but negative for HV-phe-
notype, these naturally- selected HV-negative strains
could be used as an ideal control for HV-positive strains
to minimize the influence of defects on the capsule.
Consistent with previous thoughts, the HV-positive strain
1112 was more likely to cause pneumonia or KLA in
naïve mice than 1084. Although the idea that the HV-
phenotype is a determinant for K. pneumoniae virulence
was suggested by the fact that the isogenic HV-negative
mutant of 1112, KPG6, notably lost its virulence to mice,
we could not exclude the possibility that the mutation of
pgi influenced the integrity of the capsule and disrupted
the synthesis of exopolysaccharides as the anti-phagocytic
ability of KPG6 in Raw264.7 macrophages was attenu-
ated. Unlike KPG6, naturally-selected HV-negative strain
1084 exhibited the wild-type level capsule-related charac-
teristics, including serum-resistance, anti-phagocytosis,
and virulence to mice. The findings suggest that HV-phe-
notype-related properties are not necessarily the same as
the properties related to capsules. Further studies are
required to differentiate the roles of the HV-phenotype
and capsule in K. pneumoniae pathogenesis.
Diabetes is a risk factor for K. pneumoniae infections
[2,22]. To clarify the role of HV-phenotype in diabetic indi-
viduals, we produced diabetes in mice using a STZ-induc-
tion method [16]. The STZ-treated diabetic mice were
raised to the age of thirty weeks to avoid immunomodify-
ing effects of STZ occurring after administration of the
drug [23], to ensure the physiological properties of clinical
diabetes occurring in mice, and to mimic middle-aged dia-
betic persons, the population most susceptible to K. pneu-
moniae infections [2,24]. In pneumonia or the KLA model
generated in the diabetic mice, bacteremia was more likely
to develop following an intratracheal- or oral-infection
with the HV-negative strain 1084 compared to that of
1112. The pathological advantages of HV-negative K. pneu-
moniae in diabetic mice implies that diabetes might pro-
vide a specialized environment permitting these strains to
disseminate from local tissues, such as the lungs and intes-
tines into the blood. Although previous studies have indi-
cated that the hyperglycemic state of diabetes provokes a
functional decline of neutrophils [25,26], phagocytosis by
neutrophils from diabetic patients of K. pneumoniae 1112
was comparable to that of 1084 (data not shown). More-
over, pulmonary infections caused by K. pneumoniae 1112
and 1084 caused similar apoptosis levels of the alveolar
macrophages in both diabetic and naïve mice (data not
shown). Given that capsules play a pivotal role in the pro-
tection of K. pneumoniae from phagocytosis [27], it is not
surprising that the well-encapsulated K. pneumoniae 1084
interacted with phagocytes in the same manner as 1112.
This implied that the HV phenotype was not essential for
the antiphagocytosis of K. pneumoniae. Thus, a mutant
library of 1084 generated using a signature-tagged muta-
genesis technique is currently under in vivo screening in
diabetic mice. Identification of the genetic requirement of
1084 with regard to virulence will provide insights into the
Figure 3 Histopathological examination of livers. Mice that had
been orally inoculated with PBS (A, B), HV-negative strain 1084 (C,
D), or HV-positive strain 1112 (E, F) (in diabetic mice) (A, C, E) with
inoculums of 105 CFU or in naive mice with inoculums of 108 CFU
(B, D, F) were euthanized at seven days post-inoculation. Arrows
indicate the area of PMN infiltration and aggregation (100 ×
magnification). Scale bar represents a distance of 1 μm.
Table 1 Virulence characteristics of K. pneumoniae 1112,
KPG6, and 1084
Characteristics K. pneumoniae strains
1112 KPG6 1084
Hypermucoviscosity Positive Negative Negative
Serum killinga Resistant Sensitive Resistant
Oral LD50b 6.9 × 106 > 109 9 × 106
Intracellular survival (%) in
Raw264.7 cellc
60.29 ± 5.04 46.77 ± 1.61 57.82 ± 2.42
Note. aIf the bacteria examined showed a reduction of 2 log10 in the surviving
counts after serum incubation, this strain was defined as serum-sensitive. If
the viability of a strain remain > 90% after 30 min-treatment, the strain was
defined as serum-resistant. bFive 8 wk old male BALB/c mice of a group were
orally inoculated with bacterial culture of a particular K. pneumoniae strain in
10-fold steps graded doses. The 50% lethal doses, based on the number of
survivors after one week, were calculated by the method of Reed and Muench
[29] expressed as colony forming units (CFU). cA particular K. pneumoniae
strain was used to infect Raw264.7 cells with m.o.i. = 100. After stringent
washes, the number of adherent and intracellular K. pneumoniae was
determined before and after gentamicin treatment. The intracellular survival
rate was calculated as 100% × (number of intracellular bacteria after
gentamicin treated for 3 h/number of adherent bacteria before gentamicin
treatment).
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means by which 1084 gains an advantage in dissemination
and proliferation in the blood of diabetic mice. To our
knowledge, this is the first study using naturally-selected
strains to evaluate the requirements of HV-phenotype for
K. pneumoniae virulence in diabetic mice. Our findings
suggest that the HV-negative strain 1084 is more virulent
than the HV-positive strain 1112 under diabetic conditions,
the naturally-selected strain 1084 may serve as an ideal
model for identifying virulence factors, rather than relying
on the HV phenotype that contributes significantly to the
pathogenesis of K. pneumoniae.
Conclusions
HV-phenotype is a virulent determinant for clinically
isolated HV-positive K. pneumoniae. However, factors
other than the HV-phenotype contribute significantly to
the virulence of K. pneumoniae isolates displaying no
HV-phenotype, particularly for systemic dissemination
under diabetic conditions.
Methods
Bacterial isolates
During a fifteen-month period from April 2002, a total of
473 non-repetitive K. pneumoniae were isolated from the
infection foci of patients who had K. pneumoniae-related
infections treated at a referral medical center in central
Taiwan. The clinical isolates, which were confirmed as K.
pneumoniae using the API 20E system (BioMerieux), were
collected from various infection foci: 11.6% were from
blood; 4%, from liver aspirates; 0.4%, from eye aspirates;
0.8%, from cerebrospinal fluid; 26.2%, from non-hepatic
abscesses; 22.8%, from sputum; 8.5%, from wound pus;
and 25.6%, from other body fluids. Due to the difficulty in
determining whether K. pneumoniae is the primary patho-
gen in a urinary tract infection, urine isolates were
excluded. If cultures were concomitantly positive in more
than one site, only that culture which was isolated from
the primary infection focus was included. One isolate per
patient was analyzed, and each isolate represented a single
case. Isolates were cultured in Luria-Bertani (LB) broth
and stored at -80°C until use. Medical records were
reviewed and information related to clinical manifestations
and underlying diseases was collected. Clinical research
was conducted according to the human experimentation
guidelines of Chung-Shan Medical University. Ethical
approval was not needed for the present study.
Determination of the hypermucoviscosity (HV) phenotype
and detection of HV-related genes
The HV phenotype display was examined with a string-
formation test as described by Fang et al [14]. Bacterial
strains to be tested were inoculated onto 5% sheep
blood plates and incubated at 37°C for 16 h. Positive of
hypermucoviscosity phenotype was defined as the
formation of viscous strings > 5 mm in length when a
standard inoculation loop was used to stretch the colony
on blood agar plates. K. pneumoniae isolates, capable of
displaying the HV-phenotype from three independent
tests were described as HV-positive and those that were
unqualified in string forming were HV-negative.
Induction of diabetes in mice
Six-week-old male C57BL/6J mice were purchased from
the National Laboratory Animal Center (NLAC, Taiwan)
and allowed to acclimatize in the animal house for one
week before experiments. Mice (25-30 g body weight)
were randomly divided into two groups. One group
received intraperitoneal injection of the pancreatic b-cell
toxin streptozotocin (STZ; Sigma) for five days (55 mg/
kg per day in 0.05 M citrate buffer, pH 4.5) [16]. The
other group received injections of citrate buffer as the
control. The serum glucose concentrations and body
weights of the mice were determined at indicative time
points after the multi-injection of STZ.
Pneumonia or KLA infection models
To recapitulate a pneumonia infection, thirty-week-old
mice were anesthetized with isoflurane and intratracheally
inoculated with 104 CFU of K. pneumoniae by intubation
with a blunt-ended needle [28]. At 20 h post-inoculation,
lungs and blood were retrieved, homogenized, and plated
onto M9 agar for enumerating bacterial counts. Based on
the KLA infection model established in our previous study
[17], groups of two to four thirty-week-old diabetic or
naïve mice were orally inoculated with 105 or 108 CFU of
K. pneumoniae, respectively. Twenty microliter of blood
was retrieved from the retroorbital sinus of infected mice
at 24, 48, and 72 h post-inoculation for enumeration of
bacterial counts. Survival of the infected mice was moni-
tored daily for seven days. For histological examination,
livers retrieved from mice were fixed in 4% paraformalde-
hyde, paraffin embedded, and stained with haematoxylin
and eosin. All the animal experiments were performed
according to NLAC guidance and the Institutional Animal
Care and Use Committee approved protocols.
Statistical analysis
Results are expressed as means ± SD. The two-sample t
test was used to test for differences between the groups
indicated. Statistical significance was determined based
on a P value ≤ 0.05. All experiments were repeated a
minimum of three times to ensure reproducibility.
Additional material
Additional file 1: Induction of diabetic mice. The file contains
supplemental figure S1 that presents the successful induction of diabetic
mice in this study.
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